Browsing Tag
semaglutide
44 posts
GLP-1 receptor agonists improve mood and metabolic health in adults with mental illness
[ad_1] Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control…
May 11, 2025
Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD
[ad_1] Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic), are yet to receive FDA approval for the…
May 9, 2025
Semaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial shows
[ad_1] In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of patients and…
May 5, 2025
What’s behind Gen Z’s skepticism about Ozempic and Wegovy
[ad_1] Despite the rise in prescriptions, young Americans remain skeptical about semaglutide, preferring natural health habits and voicing…
April 25, 2025
Semaglutide Use Could Prevent Up to 2 Million MACE in 10 Years, Model Suggests
[ad_1] Nearly 2 million major cardiac events could be avoided through the use of semaglutide at its indicated…
April 10, 2025
Older Americans support insurance coverage for obesity medications
[ad_1] A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity…
March 28, 2025
Concerns over Ozempic misuse and eating disorder risks prompt calls for increased screening
[ad_1] Initially developed to treat type 2 diabetes, drugs such as Ozempic and Wegovy (brand names for semaglutide)…
March 14, 2025
How Ozempic and other GLP-1 agonist drugs turn down ‘food noise’ and cravings
[ad_1] When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in…
March 7, 2025
Study Shows Semaglutide Holds Promise in Reducing Alcohol Cravings
[ad_1] Emerging research suggests that semaglutide (Ozempic; Eli Lilly) may help individuals with alcohol use disorder (AUD) reduce…
February 21, 2025
Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugs
[ad_1] Monthly prescriptions for obesity medications reached 1.5 million in February 2024, with semaglutide (Wegovy) and tirzepatide (Zepbound)…
February 3, 2025